New England Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-676
Closed -$15K 156
2020
Q2
$15K Hold
676
﹤0.01% 146
2020
Q1
$15K Sell
676
-61,400
-99% -$1.68M ﹤0.01% 150
2019
Q4
$1.83M Buy
62,076
+12,200
+24% +$332K 0.03% 79
2019
Q3
$1.33M Hold
49,876
0.02% 95
2019
Q2
$1.69M Sell
49,876
-28,831
-37% -$936K 0.03% 83
2019
Q1
$2.52M Buy
78,707
+67,507
+603% +$2.08M 0.05% 65
2018
Q4
$353K Sell
11,200
-10,600
-49% -$347K 0.01% 127
2018
Q3
$761K Buy
+21,800
New +$767K 0.01% 113

Other funds holding ELAN

New England Asset Management's ELAN Position: Q3 2020 in Review

New England Asset Management sold out of Elanco Animal Health (ELAN) in Q3 2020, closing a stake of 676 shares — an estimated $15K sold.

New England Asset Management first reported a position in ELAN in Q3 2018 and held it in 8 quarters. The position peaked at $2.52M in Q1 2019. 361 funds tracked by Wall St. Rank hold ELAN as of Q3 2020.

  • New England Asset Management reported no remaining Elanco Animal Health position as of Q3 2020 after selling out during the quarter.
  • New England Asset Management sold 676 Elanco Animal Health shares in Q3 2020, an estimated $15K.
  • New England Asset Management first reported a position in Elanco Animal Health in Q3 2018 and held it in 8 quarters.
  • New England Asset Management's Elanco Animal Health position peaked at $2.52M in Q1 2019.
  • 361 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2020.

Based on New England Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.